| nAb | Neutralizing Antibody |
| mAb | Monoclonal Antibody |
| RBD | Receptor binding domain |
| ACE2 | Angiotensin-converting enzyme 2 |
| S-protein | Spike glycoprotein |
| NTD | N-terminal domain |
| CPT | Convalescent plasma therapy |
| ADE | Antibody-dependent enhancement |
| HCAbs | Heavy chain antibodies |
| IL-6 | Interleukin 6 |
| CDRH | Complementarity-determining regions of heavy-chain |
| FDA | Food & Drug Administration |
| IgA | Immunoglobulin A |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| VH | Variable domain heavy chain |
| VOI | Variant of Interest |
| VOC | Variant of Concern |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.